and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir, a long-acting insulin, "failed to take into consideration patient access to affordable, long-acting insulin ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics without an ...

In the wake of Novo Nordisk's plan to pull its long-acting insulin (Levemir) from the market by the end of 2024, some patients have described events of hypoglycemia and rapid glucose fluctuations ...

Some patients with type 2 diabetes may also require insulin after initial treatment with diet, exercise and tablets. Levemir ® lowers your blood sugar level after injection. The effect may last ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

Lipska said that switching insulin brands is problematic for some patients, noting, “Novo Nordisk stopped making Levemir which was a very popular type of insulin. Interestingly, it was ...

"Our mission is to ensure a stable supply of affordable insulin options, starting with our lead biosimilar, R-biolin, and continuing with our next project, a biosimilar to Levemir." rBIO's ...